Medtronic plc — Director's Dealing 2018

Aug 23, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2018-08-22

Reporting Person: COYLE MICHAEL J (EVP & Group Pres, Cardiac&Vasc)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-22	Ordinary Shares	M	23175	$43.15	Acquired	190680	Direct
2018-08-22	Ordinary Shares	M	70984	$37.53	Acquired	261664	Direct
2018-08-22	Ordinary Shares	M	84060	$34.88	Acquired	345724	Direct
2018-08-22	Ordinary Shares	S	145544	$95.498	Disposed	200180	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-22	Stock Option (Right to Buy)	$43.15	M	23175	Disposed	2020-02-01	Ordinary Shares (23175)	Direct
2018-08-22	Stock Option (Right to Buy)	$37.53	M	70984	Disposed	2020-08-02	Ordinary Shares (70984)	Direct
2018-08-22	Stock Option (Right to Buy)	$34.88	M	84060	Disposed	2021-08-01	Ordinary Shares (84060)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	250	Indirect
Ordinary Shares	4104	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.365 to $95.665, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.

F2: This option to purchase 23,175 ordinary shares of New Medtronic for $43.15 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 23,175 Medtronic common stock shares for $43.15 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F3: This option to purchase 70,984 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 70,984 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F4: This option to purchase 84,060 New Medtronic ordinary shares for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 84,060 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.